Back Home
  • Global Newsroom
    • Australia
      • National Health and Medical Research Council
      • Therapeutic Goods Administration
    • Austria
      • Federal Ministry of Health and Women
      • Ludwig Boltzmann Institute HTA
    • Belgium
      • The Federal Public Service
      • Belgian Health Care Knowledge Centre
      • INAMI
    • Canada
      • CADTH News
    • Cochrane
      • Cochrane Editorials News
      • Cochrane News
    • Denmark
      • Danish Health Authority
      • Danish Medicines Agency
      • Danish Ministry of Health
      • Danish Patient Safety Authority
      • Health Data Protection Agency
      • Centre for Innovative Medicinal Technology
    • Europe
      • Euractiv
      • EUnetHTA
        • EUnetHTA Documents
        • EUnetHTA News
      • European Medicines Agency
      • EuroScan International Network
        • EuroScan New technologies News
        • EuroScan – News
    • Finland
      • Finlands Ministry of Social Affairs and Health
      • Finlands National Institute for Health and Welfare
    • France
      • French National Authority for Health
      • French National Health Insurance
      • Ministry of Solidarity and Health
    • Germany
      • DIMDI
      • Federal Joint Committee
      • Federal Ministry of Health
      • Iris Institute
      • IQWiG News
    • ISPOR
      • ISPOR News
    • Norway
      • Norwegian Institute for Public Health
      • Norwegian Ministry of Health and Care Services
      • Norwegian Regional Health Authorities
    • Sweden
      • Läkemedelsindustriföreningen
      • Medical Products Agency Läkemedelsverket
      • National Board of Health and Welfare
      • Swedish agency for HTA
      • Janusinfo
      • Dental and Pharmaceutical Benefits Agency
        • TLV consumable items news
        • TLV medicinal products news
        • Press Releases by TLV
        • TLV News
      • Swedish Government
      • Swedish Public Health Agency
    • Switzerland
      • Federal Office of Public Health
    • The Netherlands
      • Dutch Healthcare Authority
      • Ministry of Health, Welfare and Sport
      • National Health Care Institute
      • ZonMw
    • The United Kingdom
      • CRD HTA Database news
      • NICE
        • Latest news from NICE
      • News from NIHR
      • NIHR Innovation Observatory
      • Pharmafile
      • UK Department of Health
      • News from HEART Consortium
    • The United States
      • Bio-ITWorld.com
      • Centers for Disease Control and Prevention
      • Centers for Medicare & Medicaid Services
      • FiercePharma
      • HealthEconomicsDotcom
      • HealthPayerIntelligence
      • Healthcare IT News
      • ICER
      • Medicare
      • National Guideline Clearinghouse
      • National Institutes of Health Director
      • News from Pharmacy Times
      • Pharma Intelligence | Informa
    • Miscellaneous
      • Healthcare Information and Management Systems Society
      • World Economic Forum
  • Resources
    • Australian Institutions
    • Austrian Institutions
    • Belgian Institutions
    • Canadian Institutions
    • Danish Institutions
    • Dutch Institutions
    • European Union Institutions
    • Finland Institutions
    • German Institutions
    • Italian Institutions
    • Norwegian Institutions
    • Swiss Institutions
    • United States Institutions
    • Other
  • Workspace
    • C01 Area
      • C01 Calendar
      • C01 File upload
      • C01 Product Development
      • C01 Reference Management
    • C02 Area
      • C02 Calendar
      • C02 File upload
      • C02 Product Development
  • HTA on Social Media
  • Log In
Home » Newsroom » Denmark » Danish Medicines Agency » Blodtryksmedicin med valsartan tilbagekaldes – opdateret

Blodtryksmedicin med valsartan tilbagekaldes – opdateret

1 Oct, 2018  in Danish Medicines Agency shared by Paul Mattheneus
Original post, click here
Share this...
Tweet about this on Twitter
Twitter
Share on Facebook
Facebook
Share on LinkedIn
Linkedin
Email this to someone
email
Share on Reddit
Reddit
Pin on Pinterest
Pinterest

This content is password protected. To view it please enter your password below:

Post navigation

  • ← McCann Health puts drug resistance, mental health on its brain trust's priority list
  • ACP vergadert over het sluisgeneesmiddel osimertinib en discussieert over de monopolieposities van geneesmiddelenfabrikanten →

· Paul Mattheneus © 2018 Mattheneus HTA Intel & Collaboration Platform ·